Response rate of lorazepam in catatonia: A developing country's perspective

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 8, 2010, Pages 1520-1522

  Tibrewal, Prashant ^a   Narayanaswamy, Janardhanan ^a   Zutshi, Amit ^a   Srinivasaraju, Ravindra ^a   Math, Suresh Bada ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Benzodiazepine; Catatonia; Electroconvulsive therapy; Lorazepam

Indexed keywords

LORAZEPAM;

ADULT; AGED; ARTICLE; CATATONIA; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HOSPITAL ADMISSION; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL HOSPITAL; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CATATONIA; DEVELOPING COUNTRIES; FEMALE; HUMANS; INDIA; LORAZEPAM; MALE; REACTION TIME; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78649514293     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.08.017     Document Type: Article

References (14)

1. Bush G., Fink M., Petrides G., Dowling F., Francis A. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 1996, 93:137-143.
2. Carroll B.T. Kahlbaum's catatonia revisited. Psychiatry Clin Neurosci 2001, 55:431-436.
3. Casey D.A. Intravenous lorazepam in psychogenic catatonia. J Clin Psychopharmacol 1987, 7:360-361.
4. Falkai P., Wobrock T., Lieberman J., Glenthoj B., Gattaz W.F., Moller H.J. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia. World J Biol Psychiatry 2005, 6:132-191.
5. Hawkins J.M., Archer K.J., Strakowski S.M., Keck P.E. Somatic treatment of catatonia. Int J Psychiatry Med 1995, 25:345-369.
6. Huang T.L. Lorazepam and diazepam rapidly relieve catatonic signs in patients with schizophrenia. Psychiatry Clin Neurosci 2005, 59:52-55.
7. Hung Y.Y., Huang T.L. Lorazepam and diazepam rapidly relieve catatonic features in major depression. Clin Neuropharmacol 2006, 29:144-147.
8. Lee J.W., Schwartz D.L., Hallmayer J. Catatonia in a psychiatric intensive care facility: incidence and response to benzodiazepines. Ann Clin Psychiatry 2000, 12:89-96.
9. Northoff G. Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology. J Neural Transm 2002, 109:1453-1467.
10. Northoff G. What catatonia can tell us about "top-down modulation": a neuropsychiatric hypothesis. Behav Brain Sci 2002, 25:555-577. discussion 578-604.
11. Pommepuy N., Januel D. Catatonia: resurgence of a concept. A review of the international literature. Encephale 2002, 28:481-492.
12. Rosebush P.I., Hildebrand A.M., Furlong B.G., Mazurek M.F. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry 1990, 51:357-362.
13. Taylor M.A., Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 2003, 160:1233-1241.
14. Ungvari G.S., Kau L.S., Wai-Kwong T., Shing N.F. The pharmacological treatment of catatonia: an overview. Eur Arch Psychiatry Clin Neurosci 2001, 251(Suppl 1):I31-I34.